Benjamin Cowling to Humans
This is a "connection" page, showing publications Benjamin Cowling has written about Humans.
Connection Strength
0.438
-
The Incubation Period Distribution of Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Clin Infect Dis. 2021 12 16; 73(12):2344-2352.
Score: 0.008
-
Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea. J Infect Dis. 2021 09 17; 224(6):949-955.
Score: 0.008
-
Accounting for Imported Cases in Estimating the Time-Varying Reproductive Number of Coronavirus Disease 2019 in Hong Kong. J Infect Dis. 2021 09 01; 224(5):783-787.
Score: 0.008
-
Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality. Nat Med. 2021 08; 27(8):1321-1323.
Score: 0.008
-
Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea. BMC Infect Dis. 2021 May 26; 21(1):485.
Score: 0.008
-
COVID-19 transmission in Hong Kong despite universal masking. J Infect. 2021 07; 83(1):92-95.
Score: 0.008
-
Face masks and COVID-19: don't let perfect be the enemy of good. Euro Surveill. 2020 12; 25(49).
Score: 0.007
-
Importance of Face Masks for COVID-19: A Call for Effective Public Education. Clin Infect Dis. 2020 11 19; 71(16):2195-2198.
Score: 0.007
-
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020 11; 26(11):1714-1719.
Score: 0.007
-
Ecologic association between influenza and COVID-19 mortality rates in European countries. Epidemiol Infect. 2020 09 11; 148:e209.
Score: 0.007
-
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions. Science. 2020 08 28; 369(6507):1106-1109.
Score: 0.007
-
Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020. Emerg Infect Dis. 2020 Oct; 26(10):2406-2410.
Score: 0.007
-
Public Health Measures to Slow Community Spread of Coronavirus Disease 2019. J Infect Dis. 2020 05 11; 221(11):1749-1751.
Score: 0.007
-
Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study. Lancet Public Health. 2020 05; 5(5):e289-e296.
Score: 0.007
-
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020 05; 5(5):e279-e288.
Score: 0.007
-
Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020 05; 26(5):676-680.
Score: 0.007
-
Rational use of face masks in the COVID-19 pandemic. Lancet Respir Med. 2020 05; 8(5):434-436.
Score: 0.007
-
Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Euro Surveill. 2020 02; 25(6).
Score: 0.007
-
The Effect of Influenza Vaccination History on Changes in Hemagglutination Inhibition Titers After Receipt of the 2015-2016 Influenza Vaccine in Older Adults in Hong Kong. J Infect Dis. 2020 01 01; 221(1):33-41.
Score: 0.007
-
Effectiveness of Partial and Full Influenza Vaccination Among Children Aged <9 Years in Hong Kong, 2011-2019. J Infect Dis. 2019 10 08; 220(10):1568-1576.
Score: 0.007
-
Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. Curr Opin Infect Dis. 2019 08; 32(4):372-379.
Score: 0.007
-
Remaining challenges for prevention and control of hand, foot, and mouth disease. Lancet Child Adolesc Health. 2019 06; 3(6):373-374.
Score: 0.007
-
The Value of Neuraminidase Inhibition Antibody Titers in Influenza Seroepidemiology. J Infect Dis. 2019 01 09; 219(3):341-343.
Score: 0.006
-
Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19. Euro Surveill. 2019 Jan; 24(5).
Score: 0.006
-
Reconciling estimates of the global influenza burden. Lancet Respir Med. 2019 01; 7(1):8-9.
Score: 0.006
-
Effectiveness of influenza vaccination on influenza-associated hospitalisations over time among children in Hong Kong: a test-negative case-control study. Lancet Respir Med. 2018 12; 6(12):925-934.
Score: 0.006
-
Emerging Enteroviruses Causing Hand, Foot and Mouth Disease, China, 2010-2016. Emerg Infect Dis. 2018 10; 24(10):1902-1906.
Score: 0.006
-
Influenza-like illness and viral aetiology in Hong Kong children. Hong Kong Med J. 2018 Oct; 24 Suppl 6(5):12-15.
Score: 0.006
-
Real-time forecasting of infectious disease epidemics. Hong Kong Med J. 2018 Oct; 24 Suppl 6(5):26-29.
Score: 0.006
-
Variation in Influenza B Virus Epidemiology by Lineage, China. Emerg Infect Dis. 2018 08; 24(8):1536-1540.
Score: 0.006
-
Immune Responses to Twice-Annual Influenza Vaccination in Older Adults in Hong Kong. Clin Infect Dis. 2018 03 05; 66(6):904-912.
Score: 0.006
-
Efficacy of inactivated influenza vaccines in young children. Lancet Child Adolesc Health. 2018 05; 2(5):307-308.
Score: 0.006
-
A concern over terminology in vaccine effectiveness studies. Euro Surveill. 2018 03; 23(10).
Score: 0.006
-
Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review. Am J Epidemiol. 2018 02 01; 187(2):378-388.
Score: 0.006
-
Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18. Euro Surveill. 2018 02; 23(8).
Score: 0.006
-
Use of influenza antivirals in patients hospitalized in Hong Kong, 2000-2015. PLoS One. 2018; 13(1):e0190306.
Score: 0.006
-
Influenza-associated mortality in Yancheng, China, 2011-15. Influenza Other Respir Viruses. 2018 01; 12(1):98-103.
Score: 0.006
-
Cohort profile: the China Ageing REespiratory infections Study (CARES), a prospective cohort study in older adults in Eastern China. BMJ Open. 2017 Nov 01; 7(10):e017503.
Score: 0.006
-
Influenza vaccination in tropical and subtropical areas. Lancet Respir Med. 2017 12; 5(12):920-922.
Score: 0.006
-
Preliminary Epidemiologic Assessment of Human Infections With Highly Pathogenic Avian Influenza A(H5N6) Virus, China. Clin Infect Dis. 2017 Aug 01; 65(3):383-388.
Score: 0.006
-
Population-Based Pediatric Hospitalization Burden of Lineage-Specific Influenza B in Hong Kong, 2004-2014. Clin Infect Dis. 2017 Jul 15; 65(2):300-307.
Score: 0.006
-
Assessment of Virus Interference in a Test-negative Study of Influenza Vaccine Effectiveness. Epidemiology. 2017 07; 28(4):514-524.
Score: 0.006
-
Viral Shedding and Transmission Potential of Asymptomatic and Paucisymptomatic Influenza Virus Infections in the Community. Clin Infect Dis. 2017 03 15; 64(6):736-742.
Score: 0.006
-
Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative. Vaccine. 2017 02 07; 35(6):856-864.
Score: 0.006
-
Comparison of incubation period distribution of human infections with MERS-CoV in South Korea and Saudi Arabia. Sci Rep. 2016 10 24; 6:35839.
Score: 0.006
-
Association between Severity of MERS-CoV Infection and Incubation Period. Emerg Infect Dis. 2016 Mar; 22(3):526-8.
Score: 0.005
-
Brief Report: Incubation Period Duration and Severity of Clinical Disease Following Severe Acute Respiratory Syndrome Coronavirus Infection. Epidemiology. 2015 Sep; 26(5):666-9.
Score: 0.005
-
Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill. 2015 Jun 25; 20(25):7-13.
Score: 0.005
-
Re: "Mendelian randomization and estimation of treatment efficacy for chronic diseases". The authors reply. Am J Epidemiol. 2014 Jan 15; 179(2):264-5.
Score: 0.005
-
Situational awareness of influenza activity based on multiple streams of surveillance data using multivariate dynamic linear model. PLoS One. 2012; 7(5):e38346.
Score: 0.004
-
Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve. Epidemiol Infect. 2008 Apr; 136(4):562-6.
Score: 0.003
-
Changing Disparities in Coronavirus Disease 2019 (COVID-19) Burden in the Ethnically Homogeneous Population of Hong Kong Through Pandemic Waves: An Observational Study. Clin Infect Dis. 2021 12 16; 73(12):2298-2305.
Score: 0.002
-
Different Transmission Dynamics of Coronavirus Disease 2019 (COVID-19) and Influenza Suggest the Relative Efficiency of Isolation/Quarantine and Social Distancing Against COVID-19 in China. Clin Infect Dis. 2021 12 06; 73(11):e4305-e4311.
Score: 0.002
-
Gut microbiome and resistome changes during the first wave of the COVID-19 pandemic in comparison with pre-pandemic travel-related changes. J Travel Med. 2021 10 11; 28(7).
Score: 0.002
-
Assessing Asymptomatic, Presymptomatic, and Symptomatic Transmission Risk of Severe Acute Respiratory Syndrome Coronavirus 2. Clin Infect Dis. 2021 09 15; 73(6):e1314-e1320.
Score: 0.002
-
Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China. Clin Infect Dis. 2021 07 01; 73(1):e79-e85.
Score: 0.002
-
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines. Epidemiology. 2021 07 01; 32(4):508-517.
Score: 0.002
-
Assessing Community Vulnerability over 3 Waves of COVID-19 Pandemic, Hong Kong, China. Emerg Infect Dis. 2021 Jul; 27(7):1935-1939.
Score: 0.002
-
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization. Vaccine. 2021 07 05; 39(30):4013-4024.
Score: 0.002
-
Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis. Lancet Infect Dis. 2021 09; 21(9):1233-1245.
Score: 0.002
-
Risk for International Importations of Variant SARS-CoV-2 Originating in the United Kingdom. Emerg Infect Dis. 2021 05; 27(5):1527-1529.
Score: 0.002
-
Upper Respiratory Infections in Schools and Childcare Centers Reopening after COVID-19 Dismissals, Hong Kong. Emerg Infect Dis. 2021 05; 27(5):1525-1527.
Score: 0.002
-
Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study. Lancet Public Health. 2021 03; 6(3):e184-e191.
Score: 0.002
-
Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 01 04; 12(1):63.
Score: 0.002
-
Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of Infection. Clin Infect Dis. 2020 12 15; 71(12):3163-3167.
Score: 0.002
-
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020 Dec; 9(1):2190-2199.
Score: 0.002
-
Anxiety levels, precautionary behaviours and public perceptions during the early phase of the COVID-19 outbreak in China: a population-based cross-sectional survey. BMJ Open. 2020 10 08; 10(10):e040910.
Score: 0.002
-
Early Insights from Statistical and Mathematical Modeling of Key Epidemiologic Parameters of COVID-19. Emerg Infect Dis. 2020 11; 26(11):e1-e14.
Score: 0.002
-
Letter to the editor: COVID-19 cases among school-aged children and school-based measures in Hong Kong, July 2020. Euro Surveill. 2020 09; 25(37).
Score: 0.002
-
Human post-infection serological response to the spike and nucleocapsid proteins of SARS-CoV-2. Influenza Other Respir Viruses. 2021 01; 15(1):7-12.
Score: 0.002
-
SARS-CoV-2 environmental contamination associated with persistently infected COVID-19 patients. Influenza Other Respir Viruses. 2020 11; 14(6):688-699.
Score: 0.002
-
Serial Interval of COVID-19 among Publicly Reported Confirmed Cases. Emerg Infect Dis. 2020 06; 26(6):1341-1343.
Score: 0.002
-
Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China. Emerg Infect Dis. 2020 Sep; 26(9).
Score: 0.002
-
Risk for Transportation of Coronavirus Disease from Wuhan to Other Cities in China. Emerg Infect Dis. 2020 05; 26(5):1049-1052.
Score: 0.002
-
From a Sprint to a Marathon in Hong Kong. N Engl J Med. 2020 04 30; 382(18):e45.
Score: 0.002
-
Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020 05; 26(5):672-675.
Score: 0.002
-
Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020 07; 20(7):793-802.
Score: 0.002
-
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020 04; 26(4):506-510.
Score: 0.002
-
Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. N Engl J Med. 2020 04 02; 382(14):1370-1371.
Score: 0.002
-
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 03 26; 382(13):1199-1207.
Score: 0.002
-
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020 Jan; 25(3).
Score: 0.002
-
Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019 09; 4(9):e473-e481.
Score: 0.002
-
Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia. Vaccine. 2019 09 16; 37(39):5891-5898.
Score: 0.002
-
Self-collected compared with professional-collected swabbing in the diagnosis of influenza in symptomatic individuals: A meta-analysis and assessment of validity. J Clin Virol. 2019 09; 118:28-35.
Score: 0.002
-
Effectiveness of EV-A71 vaccination in prevention of paediatric hand, foot, and mouth disease associated with EV-A71 virus infection requiring hospitalisation in Henan, China, 2017-18: a test-negative case-control study. Lancet Child Adolesc Health. 2019 10; 3(10):697-704.
Score: 0.002
-
Influenza epidemiology and influenza vaccine effectiveness during the 2015-2016 season: results from the Global Influenza Hospital Surveillance Network. BMC Infect Dis. 2019 May 14; 19(1):415.
Score: 0.002
-
Age-specific differences in the dynamics of protective immunity to influenza. Nat Commun. 2019 04 10; 10(1):1660.
Score: 0.002
-
Population-based estimates of the burden of pneumonia hospitalizations in Hong Kong, 2011-2015. Eur J Clin Microbiol Infect Dis. 2019 Mar; 38(3):553-561.
Score: 0.002
-
Measurement of Vaccine Direct Effects Under the Test-Negative Design. Am J Epidemiol. 2018 12 01; 187(12):2686-2697.
Score: 0.002
-
Spectrum of Enterovirus Serotypes Causing Uncomplicated Hand, Foot, and Mouth Disease and Enteroviral Diagnostic Yield of Different Clinical Samples. Clin Infect Dis. 2018 11 13; 67(11):1729-1735.
Score: 0.002
-
Surveillance and public health response for travelers returning from MERS-CoV affected countries to Gyeonggi Province, Korea, 2016-2017. Travel Med Infect Dis. 2019 Sep - Oct; 31:101350.
Score: 0.002
-
Mitigation of Influenza B Epidemic with School Closures, Hong Kong, 2018. Emerg Infect Dis. 2018 11; 24(11):2071-2073.
Score: 0.002
-
Influenza Transmission Dynamics in Urban Households, Managua, Nicaragua, 2012-2014. Emerg Infect Dis. 2018 10; 24(10):1882-1888.
Score: 0.002
-
Estimation of excess mortality and hospitalisation associated with the 2009 pandemic influenza. Hong Kong Med J. 2018 Oct; 24 Suppl 6(5):19-22.
Score: 0.002
-
The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014-17. Vaccine. 2018 10 01; 36(41):6117-6123.
Score: 0.002
-
Population Serologic Immunity to Human and Avian H2N2 Viruses in the United States and Hong Kong for Pandemic Risk Assessment. J Infect Dis. 2018 08 24; 218(7):1054-1060.
Score: 0.002
-
What is missing in surveillance for control of antimicrobial resistance? Lancet Infect Dis. 2018 06; 18(6):597-598.
Score: 0.002
-
Ambient ozone and influenza transmissibility in Hong Kong. Eur Respir J. 2018 05; 51(5).
Score: 0.002
-
Influenza Vaccine Effectiveness Against Influenza A(H3N2) Hospitalizations in Children in Hong Kong in a Prolonged Season, 2016/2017. J Infect Dis. 2018 04 11; 217(9):1365-1371.
Score: 0.002
-
Impact of antibiotic stewardship programmes in Asia: a systematic review and meta-analysis. J Antimicrob Chemother. 2018 04 01; 73(4):844-851.
Score: 0.002
-
Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. Vaccine. 2018 05 03; 36(19):2673-2682.
Score: 0.002
-
Epidemiology of Recurrent Hand, Foot and Mouth Disease, China, 2008-2015. Emerg Infect Dis. 2018 03; 24(3).
Score: 0.002
-
Defining the sizes of airborne particles that mediate influenza transmission in ferrets. Proc Natl Acad Sci U S A. 2018 03 06; 115(10):E2386-E2392.
Score: 0.002
-
Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis. Am J Epidemiol. 2018 02 01; 187(2):389-397.
Score: 0.002
-
Parental perspectives on hand, foot, and mouth disease among children in Hong Kong: a longitudinal study. Epidemiol Infect. 2018 02; 146(3):324-332.
Score: 0.002
-
Evaluation of animal-to-human and human-to-human transmission of influenza A (H7N9) virus in China, 2013-15. Sci Rep. 2018 01 11; 8(1):552.
Score: 0.002
-
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018 03 31; 391(10127):1285-1300.
Score: 0.001
-
Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Euro Surveill. 2017 12; 22(50).
Score: 0.001
-
Estimating the incubation period of hand, foot and mouth disease for children in different age groups. Sci Rep. 2017 11 28; 7(1):16464.
Score: 0.001
-
Epidemiology of Reemerging Scarlet Fever, Hong Kong, 2005-2015. Emerg Infect Dis. 2017 10; 23(10):1707-1710.
Score: 0.001
-
The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis. BMC Med. 2017 08 21; 15(1):159.
Score: 0.001
-
Epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus in Guangdong, 2016 to 2017. Euro Surveill. 2017 Jul 06; 22(27).
Score: 0.001
-
Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013-17: an epidemiological study of laboratory-confirmed case series. Lancet Infect Dis. 2017 08; 17(8):822-832.
Score: 0.001
-
Influenza vaccine effectiveness against influenza-associated hospitalization in 2015/16 season, Beijing, China. Vaccine. 2017 05 25; 35(23):3129-3134.
Score: 0.001
-
Disease burden of 2013-2014 seasonal influenza in adults in Korea. PLoS One. 2017; 12(3):e0172012.
Score: 0.001
-
A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes. PLoS One. 2016; 11(11):e0165978.
Score: 0.001
-
CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement. Influenza Other Respir Viruses. 2017 01; 11(1):2-14.
Score: 0.001
-
Generalised cost-effectiveness analysis for breast cancer prevention and care in Hong Kong Chinese. Hong Kong Med J. 2015 Dec; 21 Suppl 6:9-12.
Score: 0.001
-
Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. Euro Surveill. 2012 Oct 18; 17(42).
Score: 0.001
-
Do low preoperative vitamin D levels reduce the accuracy of quick parathyroid hormone in predicting postthyroidectomy hypocalcemia? Ann Surg Oncol. 2013 Mar; 20(3):739-45.
Score: 0.001